Redmile Group

Summary

In 2007 was created Redmile Group, which is appeared as VC. The leading representative office of defined VC is situated in the San Francisco. The venture was found in North America in United States.

Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Audentes Therapeutics, Foundation Medicine, Afferent Pharmaceuticals Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Redmile Group, startups are often financed by MPM Capital, Third Rock Ventures, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Fidelity Management and Research Company, Samsara BioCapital, Rock Springs Capital. In the next rounds fund is usually obtained by Deerfield, Wild Basin Investments, Three Leaf Ventures.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in 7-12 investment rounds annually. This Redmile Group works on 19 percentage points more the average amount of lead investments comparing to the other organizations. When the investment is from Redmile Group the average startup value is 100-500 millions dollars. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.

Besides them, we counted 4 critical employees of this fund in our database.